ACYCLIC ANALOGS OF 2-(4-PHENYLPIPERIDINO)CYCLOHEXANOL (VESAMICOL) - CONFORMATIONALLY MOBILE INHIBITORS OF VESICULAR ACETYLCHOLINE TRANSPORT

被引:26
作者
EFANGE, SMN
MICHELSON, RH
DUTTA, AK
PARSONS, SM
机构
[1] UNIV MINNESOTA,DEPT MED CHEM,MINNEAPOLIS,MN 55455
[2] UNIV CALIF SANTA BARBARA,DEPT CHEM,SANTA BARBARA,CA 93106
关键词
D O I
10.1021/jm00112a044
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Several 1,3-disubstituted propan-2-ols and one alpha,beta-disubstituted ethanol (11i) were synthesized and evaluated as potential acyclic mimics of the vesicular acetylcholine transport inhibitor 2-(4-phenylpiperidinyl)cyclohexanol (1, vesamicol, AH5183). Analogues containing the 4-phenylpiperidyl fragment (11a, 11b) were more potent than those containing the 4-phenylpiperazyl moiety (11e, 11f). Substitution at the second terminal carbon of the propyl (or ethyl) fragment with simple lipophilic aryl substituents yielded potent inhibitors of vesicular acetylcholine storage, including (-)-11a and d-11i, which are equipotent with vesamicol. However, the activity of analogues containing bicyclic aryl groups was susceptible to aryl substitution patterns (11g vs 11h), indicating a definite receptor site topography. In addition, the inhibitory activity of these acyclic analogues was enantioselective, exhibiting a preference, similar to the parent vesamicol, for the levorotatory isomer [(-)-11a vs (+)-11a]. Therefore, the simple lipophilic acyclic vicinal amino alcohols may successfully mimic the biological activity of vesamicol.
引用
收藏
页码:2638 / 2643
页数:6
相关论文
共 12 条
  • [11] THE VESICULAR ACETYLCHOLINE TRANSPORT-SYSTEM
    MARSHALL, IG
    PARSONS, SM
    [J]. TRENDS IN NEUROSCIENCES, 1987, 10 (04) : 174 - 177
  • [12] SYNTHESIS, INVITRO ACETYLCHOLINE-STORAGE-BLOCKING ACTIVITIES, AND BIOLOGICAL PROPERTIES OF DERIVATIVES AND ANALOGS OF TRANS-2-(4-PHENYLPIPERIDINO)CYCLOHEXANOL (VESAMICOL)
    ROGERS, GA
    PARSONS, SM
    ANDERSON, DC
    NILSSON, LM
    BAHR, BA
    KORNREICH, WD
    KAUFMAN, R
    JACOBS, RS
    KIRTMAN, B
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (06) : 1217 - 1230